307 related articles for article (PubMed ID: 22576723)
1. Evaluation of Anterior Vertebral Interbody Fusion Using Osteogenic Mesenchymal Stem Cells Transplanted in Collagen Sponge.
Yang W; Dong Y; Hong Y; Guang Q; Chen X
Clin Spine Surg; 2016 May; 29(4):E201-7. PubMed ID: 22576723
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation.
Nakajima T; Iizuka H; Tsutsumi S; Kayakabe M; Takagishi K
Spine (Phila Pa 1976); 2007 Oct; 32(22):2432-6. PubMed ID: 18090081
[TBL] [Abstract][Full Text] [Related]
3. Experimental posterolateral spinal fusion with porous ceramics and mesenchymal stem cells.
Cinotti G; Patti AM; Vulcano A; Della Rocca C; Polveroni G; Giannicola G; Postacchini F
J Bone Joint Surg Br; 2004 Jan; 86(1):135-42. PubMed ID: 14765881
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
Kai T; Shao-qing G; Geng-ting D
Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
[TBL] [Abstract][Full Text] [Related]
6. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
[TBL] [Abstract][Full Text] [Related]
7. The impact of collagen sponge composite bone marrow mesenchymal stem cells (BMSCs) in inducing interbody fusion.
Zheng WD; Ming JJ; Chang WL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5822-5827. PubMed ID: 30280761
[TBL] [Abstract][Full Text] [Related]
8. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
[TBL] [Abstract][Full Text] [Related]
9. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
10. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
11. Low-intensity pulsed ultrasound enhances posterior spinal fusion implanted with mesenchymal stem cells-calcium phosphate composite without bone grafting.
Hui CF; Chan CW; Yeung HY; Lee KM; Qin L; Li G; Leung KS; Hu YY; Cheng JC
Spine (Phila Pa 1976); 2011 Jun; 36(13):1010-6. PubMed ID: 21325987
[TBL] [Abstract][Full Text] [Related]
12. Construction of artificial laminae of the vertebral arch using bone marrow mesenchymal stem cells transplanted in collagen sponge.
Dong Y; Chen X; Wang M; Hong Y
Spine (Phila Pa 1976); 2012 Apr; 37(8):648-53. PubMed ID: 21857394
[TBL] [Abstract][Full Text] [Related]
13. The use of fluorescence-labeled mesenchymal stem cells in poly(lactide-co-glycolide)/hydroxyapatite/collagen hybrid graft as a bone substitute for posterolateral spinal fusion.
Huang JW; Lin SS; Chen LH; Liu SJ; Niu CC; Yuan LJ; Wu CC; Chen WJ
J Trauma; 2011 Jun; 70(6):1495-502. PubMed ID: 21817989
[TBL] [Abstract][Full Text] [Related]
14. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
15. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion.
Minamide A; Yoshida M; Kawakami M; Yamasaki S; Kojima H; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2005 May; 30(10):1134-8. PubMed ID: 15897826
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheep.
Wheeler DL; Lane JM; Seim HB; Puttlitz CM; Itescu S; Turner AS
Spine J; 2014 Mar; 14(3):435-44. PubMed ID: 24438940
[TBL] [Abstract][Full Text] [Related]
17. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic mesenchymal precursor cells (MPCs) combined with an osteoconductive scaffold to promote lumbar interbody spine fusion in an ovine model.
Wheeler DL; Fredericks DC; Dryer RF; Bae HW
Spine J; 2016 Mar; 16(3):389-99. PubMed ID: 26291397
[TBL] [Abstract][Full Text] [Related]
19. Instrumented anterior lumbar interbody fusion with equine bone protein extract.
Li H; Zou X; Springer M; Briest A; Lind M; Bünger C
Spine (Phila Pa 1976); 2007 Feb; 32(4):E126-9. PubMed ID: 17304121
[TBL] [Abstract][Full Text] [Related]
20. Effects of fibronectin on osteoinductive capability of fresh iliac bone marrow aspirate in posterolateral spinal fusion in rabbits.
Koga A; Tokuhashi Y; Ohkawa A; Nishimura T; Takayama K; Ryu J
Spine (Phila Pa 1976); 2008 May; 33(12):1318-23. PubMed ID: 18496343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
